NVCR News and Press, NovoCure Limited From 12/04/19

Shares of NovoCure  (NASDAQ: NVCR) , which makes devices for treating cancerous solid tumors with electric fields, rocketed 28.7% last month, according to data from  S&P Global Market Intelligence . For context, the S&P 500 returned 3.6% in November. The  healthc...

The program includes research grants and career development awards totaling more than $2 million over the next three years Novocure (NASDAQ: NVCR) and the American Association for Cancer Research (AACR) announce today their 2 nd Annual AACR-Novocure Grants for Tumor Treating Fields Re...

Novocure (NASDAQ: NVCR) announced today that William Doyle, Novocure’s Executive Chairman, will participate in the Evercore ISI 2019 HealthCONx Conference on December 5, 2019, in Boston. Mr. Doyle’s presentation will begin at 12:30 p.m. EST. Mr. Doyle will also participate in ...

Background Cancers of the brain (gliomas) are rare, yet fast-growing and deadly. Per a thorough 2017 study , the incidence rate is 22.64 Americans per 100,000 population. Although there has been some success with NovoCure's (NVCR) Optune system (more on this later), multiple recent drug t...

Healthcare Pulse Healthcare is at its all-time highs eclipsing the highs recorded a year earlier during the Oct-Nov 2018 period. Of course, if one looks at the broader market which has been recording such all-time highs since the summer of this year, it's understandable to shrug shoulders ...

Presentations on Tumor Treating Fields cover a broad and growing range of topics, with nearly 80 percent of presentations prepared by external authors Novocure (NASDAQ: NVCR) today announced 43 presentations on Tumor Treating Fields, including three oral presentations, will be featured...

In this week's episode of Industry Focus: Healthcare , host Shannon Jones talks with the Fool's med-tech guru, contributor Brian Feroldi, about three exciting companies listeners will want to add to their watch lists. Learn more about the businesses behind Cutera  (NASDAQ: CUTR) , Nov...

The biotech industry in Europe remains fragmented due to limited early stage capital and more risk-averse investor sentiment. While a small group of companies have successfully developed new products and financed adequate research and development, many other small ones struggle to get by with co...

China spent $137 billion on healthcare in 2018 and could spend up to $170 billion annually by 2023. Two exciting biotech companies ,  BeiGene (NASDAQ: BGNE)  and Zai Lab (NASDAQ: ZLAB) , allow investors an opportunity to get in on the action while it's still early. And why ...

NovoCure Limited (NVCR) Q3 2019 Earnings Conference Call October 31, 2019 8:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Finance & Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - Chief...